Institutional investors purchased a net $2.7 million shares of DRRX during the quarter ended June 2017, and now own 46.24% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INGALLS & SNYDER LLC Bought 4.4 Million shares of DURECT Corp
ASYMMETRY CAPITAL MANAGEMENT LP Bought 1.0 Million shares of DURECT Corp
SPRINGBOK CAPITAL MANAGEMENT LLC Bought 557.2 Thousand shares of DURECT Corp